Latest News
Medtronic invests in ICE technology companies to expand cardiac ablation portfolio
3 June 2026 - Healthcare technology company Medtronic plc (NYSE: MDT) announced on Wednesday that it is making strategic investments in two privately held intracardiac echocardiography (ICE) catheter developers, aiming to strengthen its cardiac ablat...
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
3 June 2026 - Insulin delivery company MiniMed (NASDAQ: MMED) announced on Wednesday that it has expanded its partnership with medical device and health care company Abbott to commercialise dual glucose-ketone sensors that will integrate exclusively ...
Arcus Biosciences enters clinical trial collaboration with Bristol Myers Squibb in kidney cancer programme
3 June 2026 - Clinical-stage biopharmaceutical company Arcus Biosciences Inc (NYSE:RCUS) announced on Wednesday that it has entered into a clinical trial collaboration and supply agreement with biopharmaceutical company Bristol Myers Squibb (BMS) (NY...
Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection
...
Evogene completes Phase 1 study of BMC128 in combination with Nivolumab
3 June 2026 - Computational chemistry company Evogene Ltd (Nasdaq:EVGN) (TASE:EVGN) announced on Tuesday the successful completion of the first-in-human (FIH) Phase 1 clinical study of BMC128, a rationally-designed live bacterial product developed by...